Strategic Global Advisors, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1580212 NEWPORT BEACH, CA

Position in ALNY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,451,867

-$94,288 QoQ

Shares Held

4,823

+3.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

#361

of 784 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 47% Shared 0% None 53%

Healthcare · as of Jun 30, 2026

Strategic Global Advisors, LLC holds $8,606,227 across 4 Biotechnology names. ALNY ranks #2 (16.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	97,747	$5,318,414
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	4,823	$1,451,867
3	ASND	Ascendis Pharma A/S	3,910	$1,042,875
4	ONC	BeOne Medicines Ltd.	2,783	$793,071

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,451,867	4,823	+3.2%	Shares	Sole	2026-08-14
2026-03-31	$1,546,155	4,673	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.